Cardiovascular effects of GLP-1 and GLP-1-based therapies: implications for the cardiovascular continuum in diabetes?BURGMAIER, M; HEINRICH, C; MARX, N et al.Diabetic medicine. 2013, Vol 30, Num 3, pp 289-299, issn 0742-3071, 11 p.Article

Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe^―/― miceVITTONE, F; LIBERMAN, A; VASIC, D et al.Diabetologia (Berlin). 2012, Vol 55, Num 8, pp 2267-2275, issn 0012-186X, 9 p.Article